Literature DB >> 22807973

Effect of prolongation of operative time on the outcome of patients with gastric carcinoma.

Tadahiro Nozoe1, Mayuko Kouno, Tomohiro Iguchi, Takashi Maeda, Takahiro Ezaki.   

Abstract

The aim of the present study was to analyze the effect of the prolongation of operative time (OT) on the prognosis of patients with gastric carcinoma. In total, 330 patients with gastric carcinoma were enrolled. Correlation of OT with clinicopathological features including the prognosis of the patients were analyzed. Although tumors of patients for whom the OT was longer proved to be at a significantly more advanced stage of disease and univariate analysis demonstrated that the prognosis of these patients was significantly unfavorable, tumor stage was the only factor independently associated with worse prognosis for the patients based on multivariate analysis. Duration of OT was not an independent prognostic indicator. However, OT is dependent on the surgical procedure to treat tumor progression of gastric carcinoma.

Entities:  

Year:  2012        PMID: 22807973      PMCID: PMC3398345          DOI: 10.3892/ol.2012.671

Source DB:  PubMed          Journal:  Oncol Lett        ISSN: 1792-1074            Impact factor:   2.967


  4 in total

1.  Negative impact of leakage on survival of patients undergoing curative resection for advanced gastric cancer.

Authors:  Han Mo Yoo; Han Hong Lee; Jung Ho Shim; Hae Myung Jeon; Cho Hyun Park; Kyo Young Song
Journal:  J Surg Oncol       Date:  2011-07-25       Impact factor: 3.454

2.  Japanese Classification of Gastric Carcinoma - 2nd English Edition -

Authors: 
Journal:  Gastric Cancer       Date:  1998-12       Impact factor: 7.370

3.  Impact of anastomotic leakage on long-term survival after total gastrectomy for carcinoma of the stomach.

Authors:  M Sierzega; P Kolodziejczyk; J Kulig
Journal:  Br J Surg       Date:  2010-07       Impact factor: 6.939

Review 4.  How do we improve outcomes for gastric cancer?

Authors:  Khay-Guan Yeoh
Journal:  J Gastroenterol Hepatol       Date:  2007-05-24       Impact factor: 4.029

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.